30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Aurinia Pharmaceuticals Inc (AUP)

Track

Over the last 90 days, Aurinia Pharmaceuticals Inc. saw significant insider selling, with total sales exceeding total purchases. Notably, Gregory Keenan, a former affiliate, engaged in multiple large proposed sales. Kevin Tang, the CEO, and other directors made substantial purchases, indicating mixed insider sentiment.
Stock chart
Ticker: AUP Exchange: TOR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
GREGORY KEENAN
Former Affiliate
2 sales — total 200,000 USD
Proposed sale 5 Jun 2026
Value US$130,792.82 | Price 344.41 | Shares 80,143
Proposed sale 5 Jun 2026
Value US$1,213,271.51 | Price 97.61 | Shares 95,981
Proposed sale 4 Jun 2026
Value US$3,365,810.65 | Price 433.14 | Shares 46,438
Buy 2 Jun 2026
Value US$1,573,870.56 | Price 15.28 | Shares 103,002
Buy 2 Jun 2026
Value US$1,573,885.84 | Price 15.28 | Shares 103,003
Buy 2 Jun 2026
Value US$3,147,756.40 | Price 15.28 | Shares 206,005
Proposed sale 2 Jun 2026
Value US$54,100,000.00 | Price 2,164.00 | Shares 25,000
Buy 1 Jun 2026
Value US$751.66 | Price 15.34 | Shares 49
Buy 1 Jun 2026
Value US$2,624,492.80 | Price 15.28 | Shares 171,760
Buy 1 Jun 2026
Value US$767.00 | Price 15.34 | Shares 50
Buy 1 Jun 2026
Value US$2,624,508.08 | Price 15.28 | Shares 171,761
Buy 1 Jun 2026
Value US$1,518.66 | Price 15.34 | Shares 99
Buy 1 Jun 2026
Value US$5,249,000.88 | Price 15.28 | Shares 343,521
Buy 29 May 2026
Value US$4,021,661.42 | Price 15.31 | Shares 262,682
Buy 29 May 2026
Value US$35,289.65 | Price 15.35 | Shares 2,299
Buy 29 May 2026
Value US$4,021,661.42 | Price 15.31 | Shares 262,682
Buy 29 May 2026
Value US$35,289.65 | Price 15.35 | Shares 2,299
Proposed sale 11 May 2026
Value US$49,677,423.84 | Price 15.84 | Shares 3,136,201
Proposed sale 11 May 2026
Value US$11,368,177.92 | Price 15.84 | Shares 717,688
Proposed sale 11 May 2026
Value US$7,927,967.52 | Price 15.84 | Shares 500,503
Buy 3 Mar 2026
Value US$2,619,437.76 | Price 14.22 | Shares 184,208
Buy 2 Mar 2026
Value US$1,645,404.32 | Price 14.21 | Shares 115,792
Buy 2 Mar 2026
Value US$1,197,429.13 | Price 14.33 | Shares 83,561
Buy 27 Feb 2026
Value US$23,008.00 | Price 14.38 | Shares 1,600
Buy 27 Feb 2026
Value US$3,033,526.68 | Price 14.12 | Shares 214,839
Buy 27 Feb 2026
Value US$4,170,000.00 | Price 13.90 | Shares 300,000
Buy 5 Aug 2025
Value US$2,336,000.00 | Price 11.68 | Shares 200,000
Buy 4 Aug 2025
Value US$1,134,000.00 | Price 11.34 | Shares 100,000
Buy 1 Aug 2025
Value US$10,120,000.00 | Price 10.12 | Shares 1,000,000
Sale 1 Aug 2025
Value US$210,000.00 | Price 10.50 | Shares 20,000
Sale 7 Mar 2025
Value US$68,350.15 | Price 8.23 | Shares 8,305
Sale 4 Mar 2025
Value US$1,306,380.24 | Price 7.92 | Shares 164,947
Sale 4 Mar 2025
Value US$444,739.68 | Price 7.92 | Shares 56,154
Sale 4 Mar 2025
Value US$456,247.44 | Price 7.92 | Shares 57,607
Sale 4 Mar 2025
Value US$467,208.72 | Price 7.92 | Shares 58,991
Buy 4 Mar 2025
Value US$809,000.00 | Price 8.09 | Shares 100,000
Buy 4 Mar 2025
Value US$3,960,000.00 | Price 7.92 | Shares 500,000
Buy 4 Mar 2025
Value US$1,184,304.00 | Price 8.00 | Shares 148,038
Sale 3 Mar 2025
Value US$97,912.00 | Price 8.00 | Shares 12,239
Sale 3 Mar 2025
Value US$1,564,744.00 | Price 8.00 | Shares 195,593
Sale 3 Mar 2025
Value US$494,872.00 | Price 8.00 | Shares 61,859
Sale 3 Mar 2025
Value US$518,976.00 | Price 8.00 | Shares 64,872
Sale 3 Mar 2025
Value US$527,216.00 | Price 8.00 | Shares 65,902
Buy 3 Mar 2025
Value US$2,822,735.24 | Price 8.02 | Shares 351,962
Buy 3 Mar 2025
Value US$802,738.40 | Price 7.97 | Shares 100,720
Buy 28 Feb 2025
Value US$3,134,348.00 | Price 7.85 | Shares 399,280
Buy 9 Dec 2024
Value US$4,545,000.00 | Price 9.09 | Shares 500,000
Buy 6 Dec 2024
Value US$3,604,000.00 | Price 9.01 | Shares 400,000
Buy 5 Dec 2024
Value US$2,673,000.00 | Price 8.91 | Shares 300,000
Sale 11 Nov 2024
Value US$38,415.51 | Price 8.43 | Shares 4,557
Sale 11 Nov 2024
Value US$44,181.63 | Price 8.43 | Shares 5,241
Sale 6 Aug 2024
Value US$96,902.19 | Price 5.31 | Shares 18,249
Sale 21 May 2024
Value US$2,984.80 | Price 5.74 | Shares 520
Sale 21 May 2024
Value US$32,316.20 | Price 5.74 | Shares 5,630
Sale 21 May 2024
Value US$32,316.20 | Price 5.74 | Shares 5,630
Sale 21 May 2024
Value US$30,146.48 | Price 5.74 | Shares 5,252
Sale 21 May 2024
Value US$30,146.48 | Price 5.74 | Shares 5,252
Sale 21 May 2024
Value US$32,201.40 | Price 5.74 | Shares 5,610
Sale 21 May 2024
Value US$32,201.40 | Price 5.74 | Shares 5,610
Sale 21 May 2024
Value US$28,390.04 | Price 5.74 | Shares 4,946
Sale 21 May 2024
Value US$28,390.04 | Price 5.74 | Shares 4,946
Sale 21 May 2024
Value US$32,316.20 | Price 5.74 | Shares 5,630
Sale 6 Mar 2024
Value US$99,551.20 | Price 5.60 | Shares 17,777
Sale 6 Mar 2024
Value US$711,093.60 | Price 5.60 | Shares 126,981
Sale 6 Mar 2024
Value US$194,941.60 | Price 5.60 | Shares 34,811
Sale 6 Mar 2024
Value US$323,372.00 | Price 5.60 | Shares 57,745
Sale 6 Mar 2024
Value US$224,064.15 | Price 5.51 | Shares 40,665
Sale 27 Feb 2024
Value US$30,073.00 | Price 6.10 | Shares 4,930
Planned sale 27 Feb 2024
Value US$30,073.00 | Price 6.10 | Shares 4,930
Planned buy 20 Feb 2024
Value CA$24,304,900.00 | Price 4,930.00 | Shares 4,930
Sale 20 Feb 2024
Value US$86,951.16 | Price 5.48 | Shares 15,867
Sale 20 Feb 2024
Value US$137,800.08 | Price 5.48 | Shares 25,146
Sale 23 May 2023
Value US$54,216.90 | Price 11.26 | Shares 4,815
Sale 23 May 2023
Value US$98,333.58 | Price 11.26 | Shares 8,733
Sale 23 May 2023
Value US$54,250.68 | Price 11.26 | Shares 4,818
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-05 2026-06-05 PrS Proposed sale
GREGORY KEENAN

Former Affiliate
80,143
344.41
US$130,793 		80,143 344.41 US$130,793
2026-06-05 2026-06-05 PrS Proposed sale
GREGORY KEENAN

Former Affiliate
95,981
97.61
US$1,213,272 		95,981 97.61 US$1,213,272
2026-06-04 2026-06-04 PrS Proposed sale
GREGORY KEENAN

Former Affiliate
46,438
433.14
US$3,365,811 		46,438 433.14 US$3,365,811
2026-06-03 2026-06-02 B Purchase
Tang, Kevin

Director of Issuer, Senior Officer of Issuer

Executive Director
103,002 +60.0%
15.28
US$1,573,871 		103,002 +60.0% 15.28 US$1,573,871
2026-06-03 2026-06-02 B Purchase
Tang, Kevin

Director of Issuer, Senior Officer of Issuer

Executive Director
103,003 +46.4%
15.28
US$1,573,886 		103,003 +46.4% 15.28 US$1,573,886
2026-06-02 2026-06-02 B Purchase
3.3
TANG KEVIN

Chief Executive Officer

Executive Director Large shareholder
206,005 +1.6%
15.28
US$3,147,756 		206,005 +1.6% 15.28 US$3,147,756
2026-06-02 2026-06-02 PrS Proposed sale
GREGORY KEENAN

Officer

Officer
25,000
2,164.00
US$54,100,000 		25,000 2,164.00 US$54,100,000
2026-06-03 2026-06-01 B Purchase
Tang, Kevin

Director of Issuer, Senior Officer of Issuer

Executive Director
49 +0.0%
15.34
US$752 		49 +0.0% 15.34 US$752
2026-06-03 2026-06-01 B Purchase
Tang, Kevin

Director of Issuer, Senior Officer of Issuer

Executive Director
171,760
15.28
US$2,624,493 		171,760 15.28 US$2,624,493
2026-06-03 2026-06-01 B Purchase
Tang, Kevin

Director of Issuer, Senior Officer of Issuer

Executive Director
50 +0.0%
15.34
US$767 		50 +0.0% 15.34 US$767
2026-06-03 2026-06-01 B Purchase
Tang, Kevin

Director of Issuer, Senior Officer of Issuer

Executive Director
171,761 +343.5%
15.28
US$2,624,508 		171,761 +343.5% 15.28 US$2,624,508
2026-06-02 2026-06-01 B Purchase
3.3
TANG KEVIN

Chief Executive Officer

Executive Director Large shareholder
99 +0.0%
15.34
US$1,519 		99 +0.0% 15.34 US$1,519
2026-06-02 2026-06-01 B Purchase
3.3
TANG KEVIN

Chief Executive Officer

Executive Director Large shareholder
343,521 +2.7%
15.28
US$5,249,001 		343,521 +2.7% 15.28 US$5,249,001
2026-06-03 2026-05-29 B Purchase
Tang, Kevin

Director of Issuer, Senior Officer of Issuer

Executive Director
262,682 +3.8%
15.31
US$4,021,661 		262,682 +3.8% 15.31 US$4,021,661
2026-06-03 2026-05-29 B Purchase
Tang, Kevin

Director of Issuer, Senior Officer of Issuer

Executive Director
2,299 +0.0%
15.35
US$35,290 		2,299 +0.0% 15.35 US$35,290
2026-06-02 2026-05-29 B Purchase
3.3
TANG KEVIN

Chief Executive Officer

Executive Director Large shareholder
262,682 +2.1%
15.31
US$4,021,661 		262,682 +2.1% 15.31 US$4,021,661
2026-06-02 2026-05-29 B Purchase
3.3
TANG KEVIN

Chief Executive Officer

Executive Director Large shareholder
2,299 +0.0%
15.35
US$35,290 		2,299 +0.0% 15.35 US$35,290
2026-05-11 2026-05-11 PrS Proposed sale
2.5
PETER GREENLEAF

Former Affiliate
3,136,201
15.84
US$49,677,424 		3,136,201 15.84 US$49,677,424
2026-05-11 2026-05-11 PrS Proposed sale
MATTHEW MAXWELL DONLEY

Former Affiliate
717,688
15.84
US$11,368,178 		717,688 15.84 US$11,368,178
2026-05-11 2026-05-11 PrS Proposed sale
JOSEPH MILLER

Former Affiliate
500,503
15.84
US$7,927,968 		500,503 15.84 US$7,927,968
2026-03-03 2026-03-03 B Purchase
3.3
TANG KEVIN
Non-Executive Director
184,208 +1.5%
14.22
US$2,619,438 		184,208 +1.5% 14.22 US$2,619,438
2026-03-03 2026-03-02 B Purchase
3.3
TANG KEVIN
Non-Executive Director
115,792 +1.0%
14.21
US$1,645,404 		115,792 +1.0% 14.21 US$1,645,404
2026-03-03 2026-03-02 B Purchase
3.3
TANG KEVIN
Non-Executive Director
83,561 +0.7%
14.33
US$1,197,429 		83,561 +0.7% 14.33 US$1,197,429
2026-03-03 2026-02-27 B Purchase
3.3
TANG KEVIN
Non-Executive Director
1,600 +0.0%
14.38
US$23,008 		1,600 +0.0% 14.38 US$23,008
2026-03-03 2026-02-27 B Purchase
3.3
TANG KEVIN
Non-Executive Director
214,839 +1.8%
14.12
US$3,033,527 		214,839 +1.8% 14.12 US$3,033,527
2026-03-03 2026-02-27 B Purchase
3.3
TANG KEVIN
Non-Executive Director
300,000 +2.6%
13.90
US$4,170,000 		300,000 +2.6% 13.90 US$4,170,000
2025-08-05 2025-08-05 B Purchase
3.3
TANG KEVIN
Non-Executive Director
200,000 +1.8%
11.68
US$2,336,000 		200,000 +1.8% 11.68 US$2,336,000
2025-08-05 2025-08-04 B Purchase
3.3
TANG KEVIN
Non-Executive Director
100,000 +0.9%
11.34
US$1,134,000 		100,000 +0.9% 11.34 US$1,134,000
2025-08-05 2025-08-01 B Purchase
3.3
TANG KEVIN
Non-Executive Director
1,000,000 +10.0%
10.12
US$10,120,000 		1,000,000 +10.0% 10.12 US$10,120,000
2025-08-05 2025-08-01 S Sale
Keenan Greg

Chief Medical Officer

Officer
20,000 -13.0%
10.50
US$210,000 		20,000 -13.0% 10.50 US$210,000
2025-03-07 2025-03-07 S Sale
Keenan Greg

Chief Medical Officer

Officer
8,305 -5.1%
8.23
US$68,350 		8,305 -5.1% 8.23 US$68,350
2025-03-04 2025-03-04 S Sale
2.5
Greenleaf Peter

Chief Executive Officer

Executive Director
164,947 -8.4%
7.92
US$1,306,380 		164,947 -8.4% 7.92 US$1,306,380
2025-03-04 2025-03-04 S Sale
Miller Joseph M

Chief Financial Officer

Officer
56,154 -8.9%
7.92
US$444,740 		56,154 -8.9% 7.92 US$444,740
2025-03-04 2025-03-04 S Sale
0.6
Robertson Stephen P.

EVP, General Counsel

Officer
57,607 -10.2%
7.92
US$456,247 		57,607 -10.2% 7.92 US$456,247
2025-03-04 2025-03-04 S Sale
Donley Matthew Maxwell

Chief Operating Officer

Officer
58,991 -8.0%
7.92
US$467,209 		58,991 -8.0% 7.92 US$467,209
2025-03-04 2025-03-04 B Purchase
3.3
TANG KEVIN
Non-Executive Director
100,000 +1.0%
8.09
US$809,000 		100,000 +1.0% 8.09 US$809,000
2025-03-04 2025-03-04 B Purchase
3.3
TANG KEVIN
Non-Executive Director
500,000 +5.3%
7.92
US$3,960,000 		500,000 +5.3% 7.92 US$3,960,000
2025-03-04 2025-03-04 B Purchase
3.3
TANG KEVIN
Non-Executive Director
148,038 +1.6%
8.00
US$1,184,304 		148,038 +1.6% 8.00 US$1,184,304
2025-03-04 2025-03-03 S Sale
Keenan Greg

Chief Medical Officer

Officer
12,239 -7.0%
8.00
US$97,912 		12,239 -7.0% 8.00 US$97,912
2025-03-04 2025-03-03 S Sale
2.5
Greenleaf Peter

Chief Executive Officer

Executive Director
195,593 -9.1%
8.00
US$1,564,744 		195,593 -9.1% 8.00 US$1,564,744
2025-03-04 2025-03-03 S Sale
Miller Joseph M

Chief Financial Officer

Officer
61,859 -8.9%
8.00
US$494,872 		61,859 -8.9% 8.00 US$494,872
2025-03-04 2025-03-03 S Sale
0.6
Robertson Stephen P.

EVP, General Counsel

Officer
64,872 -10.3%
8.00
US$518,976 		64,872 -10.3% 8.00 US$518,976
2025-03-04 2025-03-03 S Sale
Donley Matthew Maxwell

Chief Operating Officer

Officer
65,902 -8.2%
8.00
US$527,216 		65,902 -8.2% 8.00 US$527,216
2025-03-04 2025-03-03 B Purchase
3.3
TANG KEVIN
Non-Executive Director
351,962 +3.9%
8.02
US$2,822,735 		351,962 +3.9% 8.02 US$2,822,735
2025-03-04 2025-03-03 B Purchase
3.3
TANG KEVIN
Non-Executive Director
100,720 +1.1%
7.97
US$802,738 		100,720 +1.1% 7.97 US$802,738
2025-03-04 2025-02-28 B Purchase
3.3
TANG KEVIN
Non-Executive Director
399,280 +4.7%
7.85
US$3,134,348 		399,280 +4.7% 7.85 US$3,134,348
2024-12-09 2024-12-09 B Purchase
3.3
TANG KEVIN
Non-Executive Director
500,000 +6.3%
9.09
US$4,545,000 		500,000 +6.3% 9.09 US$4,545,000
2024-12-09 2024-12-06 B Purchase
3.3
TANG KEVIN
Non-Executive Director
400,000 +5.3%
9.01
US$3,604,000 		400,000 +5.3% 9.01 US$3,604,000
2024-12-09 2024-12-05 B Purchase
3.3
TANG KEVIN
Non-Executive Director
300,000 +4.1%
8.91
US$2,673,000 		300,000 +4.1% 8.91 US$2,673,000
2024-11-12 2024-11-11 S Sale
3.3
Bailey Jeffrey Allen
Non-Executive Director
4,557 -25.4%
8.43
US$38,416 		4,557 -25.4% 8.43 US$38,416
2024-11-12 2024-11-11 S Sale
Smith Karen L.
Non-Executive Director
5,241 -29.3%
8.43
US$44,182 		5,241 -29.3% 8.43 US$44,182
2024-08-08 2024-08-06 S Sale
Habig Scott Michael

Chief Commercial Officer

Officer
18,249 -3.8%
5.31
US$96,902 		18,249 -3.8% 5.31 US$96,902
2024-05-22 2024-05-21 S Sale
2.4
Balakrishnan Brinda
Non-Executive Director
520 -2.9%
5.74
US$2,985 		520 -2.9% 5.74 US$2,985
2024-05-22 2024-05-21 S Sale
MacKay-Dunn R. Hector
Non-Executive Director
5,630 -23.2%
5.74
US$32,316 		5,630 -23.2% 5.74 US$32,316
2024-05-22 2024-05-21 S Sale
MacKay-Dunn R. Hector
Non-Executive Director
5,630 -23.2%
5.74
US$32,316 		5,630 -23.2% 5.74 US$32,316
2024-05-22 2024-05-21 S Sale
Billen Daniel
Non-Executive Director
5,252 -15.7%
5.74
US$30,146 		5,252 -15.7% 5.74 US$30,146
2024-05-22 2024-05-21 S Sale
Billen Daniel
Non-Executive Director
5,252 -15.7%
5.74
US$30,146 		5,252 -15.7% 5.74 US$30,146
2024-05-22 2024-05-21 S Sale
0.6
Leversage Jill
Non-Executive Director
5,610 -30.3%
5.74
US$32,201 		5,610 -30.3% 5.74 US$32,201
2024-05-22 2024-05-21 S Sale
0.6
Leversage Jill
Non-Executive Director
5,610 -30.3%
5.74
US$32,201 		5,610 -30.3% 5.74 US$32,201
2024-05-22 2024-05-21 S Sale
Jayne David R.W.
Non-Executive Director
4,946 -10.0%
5.74
US$28,390 		4,946 -10.0% 5.74 US$28,390
2024-05-22 2024-05-21 S Sale
Jayne David R.W.
Non-Executive Director
4,946 -10.0%
5.74
US$28,390 		4,946 -10.0% 5.74 US$28,390
2024-05-22 2024-05-21 S Sale
3.6
MacKay-Dunn, R. Hector

Director of Issuer

Non-Executive Director
5,630 -42.6%
5.74
US$32,316 		5,630 -42.6% 5.74 US$32,316
2024-03-07 2024-03-06 S Sale
Habig Scott Michael

Chief Commercial Officer

Officer
17,777 -3.6%
5.60
US$99,551 		17,777 -3.6% 5.60 US$99,551
2024-03-07 2024-03-06 S Sale
2.5
Greenleaf Peter

Chief Executive Officer

Executive Director
126,981 -7.7%
5.60
US$711,094 		126,981 -7.7% 5.60 US$711,094
2024-03-07 2024-03-06 S Sale
Miller Joseph M

Chief Financial Officer

Officer
34,811 -6.6%
5.60
US$194,942 		34,811 -6.6% 5.60 US$194,942
2024-03-07 2024-03-06 S Sale
0.6
Robertson Stephen P.

EVP, General Counsel

Officer
57,745 -11.5%
5.60
US$323,372 		57,745 -11.5% 5.60 US$323,372
2024-03-07 2024-03-06 S Sale
Donley Matthew Maxwell

EVP, Ops & Strategy

Officer
40,665 -6.5%
5.51
US$224,064 		40,665 -6.5% 5.51 US$224,064
2024-02-29 2024-02-27 S Sale
Knappertz Volker

EVP, Research and Development

Officer
4,930 -1.5%
6.10
US$30,073 		4,930 -1.5% 6.10 US$30,073
2024-02-29 2024-02-27 PlS Planned sale
Knappertz, Volker

Senior Officer of Issuer

Officer
4,930 -16.0%
6.10
US$30,073 		4,930 -16.0% 6.10 US$30,073
2024-02-26 2024-02-20 PP Planned purchase
Donley, Matthew

Senior Officer of Issuer

Officer
4,930 +7.9%
4,930.00
CA$24,304,900 		4,930 +7.9% 4,930.00 CA$24,304,900
2024-02-22 2024-02-20 S Sale
Habig Scott Michael

Chief Commercial Officer

Officer
15,867 -3.1%
5.48
US$86,951 		15,867 -3.1% 5.48 US$86,951
2024-02-22 2024-02-20 S Sale
Knappertz Volker

EVP, Research and Development

Officer
25,146 -7.2%
5.48
US$137,800 		25,146 -7.2% 5.48 US$137,800
2023-05-23 2023-05-23 S Sale
0.6
Leversage Jill
Non-Executive Director
4,815 -20.6%
11.26
US$54,217 		4,815 -20.6% 11.26 US$54,217
2023-05-23 2023-05-23 S Sale
Jayne David R.W.
Non-Executive Director
8,733 -15.0%
11.26
US$98,334 		8,733 -15.0% 11.26 US$98,334
2023-05-23 2023-05-23 S Sale
MacKay-Dunn R. Hector
Non-Executive Director
4,818 -16.6%
11.26
US$54,251 		4,818 -16.6% 11.26 US$54,251
Explore more

More insider trading research around Aurinia Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America